The devastating AIDS epidemic in the 1980s led me to a career in the area of infectious diseases. While the major motivation for working in this area is to prevent or treat infections, I’ve also always loved the intellectual detective work involved in deciphering an illness.
My strong desire to investigate HIV led me to take part in and then lead HIV vaccine trials. Along the way, I learned the science of vaccinology. The interest I have in vaccines has increased over time, as the impact of vaccines on the health of children and adults is truly tremendous.
In the area of HIV biology, my laboratory focuses on the assembly process of the virus. I’m fascinated with how the virus interacts with host cells, especially with the host trafficking machinery. We are investigating how the HIV envelope protein becomes incorporated into budding particles and defining the cellular pathways that direct this process. Another project focuses on the cellular pathways that direct the internalization of HIV particles by macrophages and microglia, and how these cell types transmit virus to other cells in their environment.
I direct vaccine trials for adults and children, which extends my research interests beyond HIV to Ebola, SARS-CoV-2 and other pathogens. My team and I are currently developing virus-like particle vaccines for Ebola, HIV and SARS-CoV-2.
I am the immediate past president of the Pediatric Infectious Diseases Society and serve on that organization’s board. I have served on numerous study sections for the National Institutes of Health and I am currently on the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration.
I am a member of the Leadership Group for the Infectious Diseases Clinical Research Collaborative, which aligns with the Division of Microbiology and Infectious Diseases within the National Institute of Allergy and Infectious Diseases. This collaborative evaluates new vaccines and treatments for infectious diseases.
It’s important to me that I provide strong leadership and mentorship to early-career physician scientists. I lead our institutional Child Health Research Career Development Award (K-12) program.
MD: University of Texas Southwestern, Dallas, TX, 1986.
Residency: Internal Medicine/Pediatrics, Ohio State University, Columbus, OH, 1986-1990.
Fellowship: Infectious Diseases, Washington University, St. Louis, MO, 1990-1993.
Pediatric infectious diseases
Infectious Diseases
HIV assembly; HIV biology/pathogenesis; HIV vaccines; vaccines and therapeutics for children (clinical trials)
Infectious Diseases
Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study. Science Advances. 2023; 9:eadj7611.
KIF16B Mediates Anterograde Transport and Modulates Lysosomal Degradation of the HIV-1 Envelope Glycoprotein. Journal of Virology. 2023; 97:e0025523.
Viral and Host Factors Regulating HIV-1 Envelope Protein Trafficking and Particle Incorporation. Viruses-Basel. 2022; 14.
Advances in HIV-1 Assembly. Viruses-Basel. 2022; 14.
Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates. Frontiers in Immunology. 2021; 12:623996.
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology. 2020; 17:35.
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology. 2020; 17:35.
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology. 2020; 17:35.
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology. 2020; 17:35.
Paul Spearman, MD, Rashmi S. Hegde, PhD ...12/5/2022
Paul Spearman, MD, Robert W. Frenck Jr., MD5/22/2022
Paul Spearman, MD, Robert W. Frenck Jr., MD9/18/2020
Paul Spearman, MD, Karnail Singh, PhD4/16/2020
Paul Spearman, MD7/3/2019
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey